Supplemental Materials to September-October 2014 Issue
S-STS_Pediatric_Version Appendices_A-F S-STS_Update_Appendices_A-H Chappell et al Pharmaceutical Sponsor Survey Chappell [...]
Editor’s Message: Special Edition of ICNS Covers Multiple Aspects of Assessment of Suicidal Ideation and Behavior
Dear Colleagues: Every year, over 800,000 people commit suicide worldwide, [...]
Prospective Assessment of Suicidal Ideation and Behavior: An Internet Survey of Pharmaceutical Sponsor Practices
by ISCTM Suicidal Ideation and Behavior Assessment Workgroup: Phillip B. [...]
Predictive Value of Baseline Electronic Columbia–Suicide Severity Rating Scale (eC–SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation
by John H. Greist, MD; James C. Mundt, PhD; Chad [...]
Comparative Validation of the S-STS, the ISST-Plus, and the C–SSRS for Assessing the Suicidal Thinking and Behavior FDA 2012 Suicidality Categories
by David V. Sheehan, MD, MBA; Larry D. Alphs, MD, [...]
Simple Measures of Hopelessness and Impulsivity are Associated with Acute Suicidal Ideation and Attempts in Patients in Psychiatric Crisis
by Cheryl B. McCullumsmith, MD, PhD; David J. Williamson, PhD; [...]
Current Assessment and Classification of Suicidal Phenomena using the FDA 2012 Draft Guidance Document on Suicide Assessment: A Critical Review
by David V. Sheehan, MD, MBA; Jennifer M. Giddens; and [...]
The Columbia–Suicide Severity Rating Scale (C–SSRS): Has the “Gold Standard” Become a Liability?
by Jennifer M. Giddens; Kathy Harnett Sheehan, PhD; and David [...]
Are Suicide Terrorists Suicidal? A Critical Assessment of the Evidence
by Ivan Sascha Sheehan, PhD Dr. Sheehan is Graduate Program [...]
Status Update on the Sheehan-Suicidality Tracking Scale (S-STS) 2014
by David V. Sheehan, MD, MBA; Jennifer M. Giddens; and [...]